Asia Pacific: China holds a significant share in the diabetes devices market in Asia Pacific, attributed to the rapidly increasing diabetic population and government initiatives to improve healthcare facilities. Japan and South Korea are also key players in the market, driven by technological advancements and growing adoption of diabetes devices.
Europe: The United Kingdom is projected to lead the diabetes devices market in Europe, supported by the rising prevalence of diabetes and favorable reimbursement policies. Germany and France are also expected to witness substantial growth due to increasing healthcare expenditure and emphasis on preventive care.